188 related articles for article (PubMed ID: 30922860)
1. Synchronous Bilateral RCC Is Associated With Poor Recurrence-Free Survival Compared With Unilateral RCC: A Single-Center Study With Propensity Score Matching Analysis.
Kim JK; Lee H; Oh JJ; Lee S; Hong SK; Lee SE; Byun SS
Clin Genitourin Cancer; 2019 Jun; 17(3):e570-e580. PubMed ID: 30922860
[TBL] [Abstract][Full Text] [Related]
2. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.
Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
Eur Urol; 2008 Oct; 54(4):855-63. PubMed ID: 18487007
[TBL] [Abstract][Full Text] [Related]
3. Prognosis and characteristics of renal cell carcinoma in hemodialysis patients: bilateral occurrence does not influence cancer-specific survival.
Takagi T; Kondo T; Izuka J; Kobayashi H; Tomita E; Hashimoto Y; Tanabe K
Int J Urol; 2011 Dec; 18(12):806-12. PubMed ID: 21917022
[TBL] [Abstract][Full Text] [Related]
4. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of functional outcome of bilateral kidney tumors after sequential surgery.
Kim JK; Kim H; Lee H; Oh JJ; Lee S; Hong SK; Kwak C; Byun SS
BMC Cancer; 2021 May; 21(1):592. PubMed ID: 34024273
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic Features and Prognosis of Sporadic Bilateral Renal Cell Carcinoma: A Series of 148 Cases.
Qi N; Li T; Ning X; Peng X; Cai L; Gong K
Clin Genitourin Cancer; 2017 Oct; 15(5):618-624. PubMed ID: 28648756
[TBL] [Abstract][Full Text] [Related]
7. Contralateral metachronous tumor occurrence is more frequently associated with distant metastases or postoperative intrarenal recurrence in renal cell carcinoma patients.
Amano H; Kondo T; Hashimoto Y; Kobayashi H; Iizuka J; Shimada K; Nakazawa H; Ito F; Tanabe K
Int J Urol; 2010 Jul; 17(7):615-22. PubMed ID: 20482658
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival in bilateral renal cell carcinoma: a retrospective single-institutional analysis of 101 patients after surgical treatment.
Becker F; Siemer S; Tzavaras A; Suttmann H; Stoeckle M
Urology; 2008 Aug; 72(2):349-53. PubMed ID: 18485459
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience.
Klatte T; Wunderlich H; Patard JJ; Kleid MD; Lam JS; Junker K; Schubert J; Böhm M; Allhoff EP; Kabbinavar FF; Crepel M; Cindolo L; De La Taille A; Tostain J; Mejean A; Soulie M; Bellec L; Bernhard JC; Ferriere JM; Pfister C; Albouy B; Colombel M; Zisman A; Belldegrun AS; Pantuck AJ
BJU Int; 2007 Jul; 100(1):21-5. PubMed ID: 17433034
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
11. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
Pahernik S; Cudovic D; Roos F; Melchior SW; Thüroff JW
BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
[TBL] [Abstract][Full Text] [Related]
12. Bilateral renal masses: pathologic concordance and impact of temporal presentation.
Arnoux V; Fiard G; Descotes JL; Rambeaud JI; Long JA
Minerva Urol Nefrol; 2012 Dec; 64(4):287-93. PubMed ID: 23288216
[TBL] [Abstract][Full Text] [Related]
13. Bilateral renal cancers: oncological and functional outcomes.
Berczi C; Thomas B; Bacso Z; Flasko T
Int Urol Nephrol; 2016 Oct; 48(10):1617-22. PubMed ID: 27379623
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
Haferkamp A; Kurosch M; Pritsch M; Hatiboglu G; Macher-Goeppinger S; Pfitzenmaier J; Pahernik S; Wagener N; Hohenfellner M
Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
[TBL] [Abstract][Full Text] [Related]
15. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
16. Metachronous renal tumours after surgical management of oncocytoma.
Childs MA; Breau RH; Umbreit EC; Lohse CM; Cheville JC; Thompson RH; Blute ML; Leibovich BC
BJU Int; 2011 Sep; 108(6):816-9. PubMed ID: 21166765
[TBL] [Abstract][Full Text] [Related]
17. [Bilateral kidney tumor. Therapy management and histopathological results with long-term follow-up of 66 patients].
Siemer S; Uder M; Zell A; Pönicke C; Humke U; Ziegler M; Stöckle M
Urologe A; 2001 Mar; 40(2):114-20. PubMed ID: 11315585
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of synchronous and metachronous bilateral breast cancer.
Kollias J; Ellis IO; Elston CW; Blamey RW
World J Surg; 2001 Sep; 25(9):1117-24. PubMed ID: 11571945
[TBL] [Abstract][Full Text] [Related]
19. METACHRONOUS COLORECTAL LIVER METASTASES HAS BETTER PROGNOSIS - IS IT TRUE?
Quireze Junior C; Brasil AMS; Morais LK; Campion ERL; Taveira EJF; Rassi MC
Arq Gastroenterol; 2018; 55(3):258-263. PubMed ID: 30540088
[TBL] [Abstract][Full Text] [Related]
20. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
Blute ML; Amling CL; Bryant SC; Zincke H
Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
